These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12152124)

  • 1. Prostaglandin E(1) ethyl ester, a new agent for topical penile therapy.
    Schanz S; Hauswirth U; Ulmer A; Fierlbeck G
    Int J Impot Res; 2002 Aug; 14(4):317-8. PubMed ID: 12152124
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy and safety of a topical alprostadil cream, Alprox-TD, for the treatment of erectile dysfunction: two phase 2 studies in mild-to-moderate and severe ED.
    Padma-Nathan H; Steidle C; Salem S; Tayse N; Yeager J; Harning R
    Int J Impot Res; 2003 Feb; 15(1):10-7. PubMed ID: 12605235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does alprostadil cream hit the spot?
    Drug Ther Bull; 2015 Feb; 53(2):21-4. PubMed ID: 25678352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transurethral alprostadil (MUSE) in erectile dysfunction].
    Comeri G; Gianneo E; Nespoli R
    Arch Ital Urol Androl; 1999 Sep; 71(4):249-51. PubMed ID: 10592541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostaglandin in the treatment of impotence].
    Tammela T
    Duodecim; 1998; 114(4):371-5. PubMed ID: 11466950
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.
    Subramonian K; Weston PM
    J Urol; 1999 Jul; 162(1):168-9. PubMed ID: 10379774
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.
    Hellstrom WJ; Lewis RW
    J Urol; 1999 Oct; 162(4):1390. PubMed ID: 10492215
    [No Abstract]   [Full Text] [Related]  

  • 8. Penile rigidity in erectile dysfunction treated with alprostadil.
    Greco E; Polonio-Balbi P
    Lancet; 1997 Dec; 350(9092):1682. PubMed ID: 9400524
    [No Abstract]   [Full Text] [Related]  

  • 9. Transdermal and topical pharmacotherapy for male sexual dysfunction.
    Ohebshalom M; Mulhall JP
    Expert Opin Drug Deliv; 2005 Jan; 2(1):115-20. PubMed ID: 16296739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E(1) intracavernosal injection therapy to oral sildenafil citrate.
    Montorsi F; Althof SE; Sweeney M; Menchini-Fabris F; Sasso F; Giuliano F
    Int J Impot Res; 2003 Dec; 15(6):444-9. PubMed ID: 14671665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group B streptococcal septicemia following intracavernous injection therapy for erectile dysfunction in diabetes.
    Nalesnik JG; Jones L; Kraus SR
    J Urol; 2004 Jul; 172(1):151-2. PubMed ID: 15201758
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: The lowest effective dose of prostaglandin E1 as treatment for erectile dysfunction.
    Kim YC
    J Urol; 1995 Nov; 154(5):1870-1. PubMed ID: 7563372
    [No Abstract]   [Full Text] [Related]  

  • 14. Intracavernous injection as an option for aging men with erectile dysfunction.
    Wespes E
    Aging Male; 2002 Sep; 5(3):177-80. PubMed ID: 12471778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical conversations: intraurethral alprostadil (MUSE). Interview by Patricia Bates.
    Lewis J; Helfrick B; Marzucco J
    Urol Nurs; 1997 Dec; 17(4):159-61. PubMed ID: 9451246
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice.
    Rajpurkar A; Dhabuwala CB
    J Urol; 2003 Jul; 170(1):159-63. PubMed ID: 12796670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of transurethal alprostadil for safety and efficacy in men with erectile dysfunction.
    Kongkanand A; Ratana-Olarn K; Wuddhikarn S; Luengwattanakit S; Tantiwong A; Ruengdilokrat S; Opanuraks J; Sripalakit S
    J Med Assoc Thai; 2002 Feb; 85(2):223-8. PubMed ID: 12081123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is topical alprostadil an usable and reliable alternative to intracavernous injection for penile dynamic duplex ultrasonography?
    Arcaniolo D; Bellastella G; Manfredi C; Terribile M; Giordano DR; Quattrone C; La Rocca R; De Sio M; Verze P; Mirone V
    Andrologia; 2020 Mar; 52(2):e13480. PubMed ID: 31710398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injection therapy for erectile dysfunction.
    Lipshultz LI
    N Engl J Med; 1996 Apr; 334(14):913-4. PubMed ID: 8596577
    [No Abstract]   [Full Text] [Related]  

  • 20. Impotence--the present and the future.
    McDermott TE
    Ir Med J; 1997 Oct; 90(6):226. PubMed ID: 9611922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.